Financials
Financial year 2024
Apotheek Antverpia from Kontich, company number BE0404751702, closed financial year 2024 with a result of € 449,079 after tax. For that financial year Apotheek Antverpia recorded revenue of € 65.6 million and equity of € 4.3 million. Compared with financial year 2023, the result moved from € -511,564 to € 449,079. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 29, 2025.
€ 4.3 million
▲ 17% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 449,079
▲ still € 511,564 loss in 2023
Profit after tax over the fiscal year.
€ 724,965
▲ 145% vs 2023
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2024. Retained profit grew to € 4.3 million.
People and assets in 2024
172.5
▲ 48.6 vs 2023
Average over the fiscal year, from the social balance sheet.
€ 7.6 million
▲ 20% vs 2023
€ 43,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 287,654
▼ 1% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
€ 2.1 million
▼ 16% vs 2023
€ 268,860 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.
€ 8 million
▼ 63% vs 2023
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 50 days on average.
€ 1.4 million
▲ 26% vs 2023
Taxes, VAT and social contributions still to pay.
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Revenue | € 57,359,573 | € 62,404,951 | € 65,932,304 | € 65,582,410 | ▼ 1% |
| Profit after taxes | € 341,449 | € 208,150 | € -511,564 | € 449,079 | ▲ € 960,643 |
| Equity | € 4,020,132 | € 4,228,282 | € 3,716,718 | € 4,334,824 | ▲ 17% |
| Total debts | € 8,752,009 | € 13,986,749 | € 26,137,624 | € 12,222,031 | ▼ 53% |
| Cash | € 481,341 | € 244,171 | € 295,602 | € 724,965 | ▲ 145% |
| Land & buildings | € 498,623 | € 668,069 | € 1,311,005 | € 1,232,511 | ▼ 6% |
| Retained profit | € 3,958,132 | € 4,166,282 | € 3,654,718 | € 4,252,824 | ▲ 16% |
| Bank debt | € 853,216 | € 986,225 | € 2,477,077 | € 2,077,532 | ▼ 16% |
| Balance sheet total | € 12,772,141 | € 18,215,031 | € 29,854,342 | € 16,556,855 | ▼ 45% |
| Employees (FTE) | 98.9 | 110.1 | 123.9 | 172.5 | ▲ 48.6 |
Key figures of Apotheek Antverpia, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to Apotheek Antverpia?
What happened at Apotheek Antverpia in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Alegria Comm. V. stepped down as director. NBB
- Déjà Vu Comm. V. stepped down as director. NBB
- Levante Comm. V. stepped down as director. NBB
- Salento Comm. V. stepped down as director. NBB
- New annual accounts for financial year 2024: profit of € 449,079. filed late Source: NBB ↗
- Alegria Comm. V. became a director. NBB
- Déjà Vu Comm. V. became a director. NBB
- Levante Comm. V. became a director. NBB
In short
From € 341,449 profit in 2021 to € 449,079 profit in 2024.
Paid € 696,967 in corporate taxes since 2021.
Best year ever: 2024, with € 449,079 profit.
Pays suppliers within 50 days on average.
Management
It owns 97.6% of Antwerps Distributie Centrum itself.
Directors
According to the 2024 annual accounts
Managing director · represented by Geert Van Genechten
Also active at: PENELOPE-ANTWERPEN, BRONKHORST, ANIMMO, ANTWERPS DISTRIBUTIE CENTRUM, FARMA DE BOND, ADC Logistics, VITAFARMA
since 2023 · until 2029
Managing director · represented by Koen Van Genechten
Also active at: PENELOPE-ANTWERPEN, BRONKHORST, ANIMMO, ANTWERPS DISTRIBUTIE CENTRUM, FARMA DE BOND, ADC Logistics, VITAFARMA
since 2023 · until 2029
Managing director · represented by Hilde Van Genechten
Also active at: PENELOPE-ANTWERPEN, BRONKHORST, ANIMMO, ANTWERPS DISTRIBUTIE CENTRUM, FARMA DE BOND, ADC Logistics, VITAFARMA
since 2023 · until 2029
Managing director · represented by Katleen Van Genechten
Also active at: PENELOPE-ANTWERPEN, BRONKHORST, ANIMMO, ANTWERPS DISTRIBUTIE CENTRUM, FARMA DE BOND, ADC Logistics, VITAFARMA
since 2023 · until 2029
Establishments
Establishment units
Physical locations of this company
Blauwesteenstraat 95
2550 Kontich
Lambrechtshoekenlaan 258
2170 Antwerpen
Active since 1 October 1977
Nationalestraat 145
2000 Antwerpen
Active since 1 January 1961
Buizegemlei 106
2650 Edegem
Active since 1 January 1961
Boechoutsesteenweg 13
2540 Hove
Active since 1 January 1961
Statielei 22
2640 Mortsel
Active since 1 January 1961
Fruithoflaan 8 10
2600 Antwerpen
Active since 1 January 1961
Hendrik Consciencestraat 34
2800 Mechelen
Active since 6 July 1990
Bondgenotenlaan 163
3000 Leuven
Active since 13 April 1995
Groenplein 20
9060 Zelzate
Active since 19 December 2007
Blauwesteenstraat 97
2550 Kontich
Active since 1 January 2022
Antwerpsesteenweg 501 box B
2500 Lier
Active since 1 January 2022
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0404.751.702
- VAT number
- BE 0404.751.702
- Registered office
- Blauwesteenstraat 95, 2550 Kontich
- Names & denominations
- Apotheek Antverpia
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 1 January 1968
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Apothekers
Detailhandel in farmaceutische producten